4th Translational Research Conference: Acute Lymphoblastic Leukaemia (ALL)

European School of Haematology (ESH) 4th Translational Research Conference: Acute Lymphoblastic Leukaemia (ALL) is organized by European School of Haematology (ESH) and will be held from May 22 - 24, 2025 at The Grand Hotel Malahide, Dublin, Leinster, Ireland.

Description:
ESH Translational Research Conference programmes are designed to place emphasis on lleading-edge basic, clinical and therapeutic research and future perspectives. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks. ESH conference delegates are invited to submit abstracts. Selected abstracts are presented as brief oral communications or posters.

Main Scientific Topics:

• The biology of T-ALL
• The biology of B-cell precursor ALL subtypes
• Specific genetic entities
• Host factors
• Measurable Residual Disease (MRD)
• Targeted therapy
• Immunotherapy
• Cell therapy

Learning Objectives:
Upon completion of this CME activity, participants will:

• Learn how to optimally diagnose and classify ALL by combining modern diagnosis algorithms and early MRD monitoring for the rapid delivery of the right treatment to the right patient;
• Review conventional therapeutic options with a focus on the role of allogeneic haemopoietic stem cell transplantation;
• Learn how to optimize the management of individual patients on the basis of individual drug metabolism, tolerance and toxicity;
• Acquire improved knowledge of new, emerging targeted or immunologic treatments and understand how they may be combined or how they could eventually replace current conventional treatment options.

The Programme Will Include:

• Plenary Sessions
• Panel Discussions
• Poster Walks
• Meet the Expert Sessions
• Keynote lectures